title: Ultrasound recognition and treatment of fetal supraventricular tachycardia with hydrops: a case report.
abstract: To manage fetal tachyarrhythmia induced hydrops, both a correct diagnosis and adequate intrauterine therapy are fundamentally important. We present a 32-week-gestational-age hydropic fetus with supraventricular tachycardia who responded dramatically after transplacental administration of high dose digoxin (1 mg intravenously daily). The baby was born at 36 weeks' gestation followed by a successful postnatal conversion. Prenatal fetal echocardiography is emphasized in determining appropriate treatment and monitoring fetal well-being which in this case resulted in a good outcome.
authors.affiliation: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC.
authors.forename: C L
authors.initials: CL
authors.lastname: Chang
authors.forename: A S
authors.initials: AS
authors.lastname: Chao
authors.forename: C D
authors.initials: CD
authors.lastname: Wu
authors.forename: R
authors.initials: R
authors.lastname: Lien
authors.forename: P J
authors.initials: PJ
authors.lastname: Cheng
mesh_terms: D000328:Adult; D004077:Digoxin / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006801:Humans; D015160:Hydrops Fetalis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011247:Pregnancy; D013617:Tachycardia, Supraventricular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016216:Ultrasonography, Prenatal
chemical_list: D004077:Digoxin